Skip to content

Clinical trials

Phase 2 Carcinoma, Merkel Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Merkel Cell Phase: Phase 2 Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20091
20121
20132
20144
20153
20161
20173
20183
20193
20204
20216
20222
20236
20242
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting11
Recruiting9
Terminated6
Unknown status4
Withdrawn4
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)7
ImmunityBio, Inc.3
M.D. Anderson Cancer Center3
Memorial Sloan Kettering Cancer Center3
4SC AG2
H. Lee Moffitt Cancer Center and Research Institute2
Philogen S.p.A.2
Abramson Cancer Center at Penn Medicine1
Burzynski Research Institute1
Dana-Farber Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Merkel Cell50
Melanoma8
Carcinoma, Non-Small-Cell Lung6
Carcinoma, Renal Cell6
Basal Cell Carcinoma5
Skin Neoplasms5
Carcinoma, Transitional Cell4
Colorectal Neoplasms4
Neoplasm Metastasis4
Uterine Cervical Neoplasms4

Trials

Showing 51 to 50 of 50. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.